Improving gene expression similarity measurement using pathway-based analytic dimension by Keum, Changwon et al.
BMC Genomics
Proceedings
Improving gene expression similarity measurement using
pathway-based analytic dimension
Changwon Keum
1, Jung Hoon Woo
2, Won Seok Oh
1,S u e - N i eP a r k
4
and Kyoung Tai No*
1,3
Addresses:
1Bioinformatics & Molecular Design Research Center (BMDRC), Seoul, Korea,
2Seoul National University Biomedical Informatics
(SNUBI), Seoul National University College of Medicine, Seoul, Korea,
3Dept. of Biotechnology, Yonsei University, Seoul, Korea and
4Division
of Genetic Toxicology, National Institute of Toxicological Research, Korea Food and Drug Administration, Seoul, Korea
E-mail: Changwon Keum - cwkeum@gmail.com; Jung Hoon Woo - hydepark83@gmail.com; Won Seok Oh - wsoh@bmdrc.org;
Sue-Nie Park - suenie@kfda.go.kr; Kyoung Tai No* - ktno@bmdrc.org
*Corresponding author
from Asia Pacific Bioinformatics Network (APBioNet) Eighth International Conference on Bioinformatics (InCoB2009)
Singapore 7-11 September 2009
Published: 3 December 2009
BMC Genomics 2009, 10(Suppl 3):S15 doi: 10.1186/1471-2164-10-S3-S15
This article is available from: http://www.biomedcentral.com/1471-2164/10/S3/S15
© 2009 Keum et al; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: Gene expression similarity measuring methods were developed and applied to
search rapidly growing public microarray databases. However, current expression similarity
measuring methods need to be improved to accurately measure similarity between gene expression
profiles from different platforms or different experiments.
Results: We devised new gene expression similarity measuring method based on pathway
information. In short, newly devised method measure similarity between gene expression profiles
after converting them into pathway based expression profiles. To evaluate pathway based gene
expression similarity measuring method, we conducted cell type classification test. Pathway based
similarity measuring method shows higher classification accuracy. Especially, pathway based
methods outperform at most 50% and 10% over conventional gene expression similarity method
when search databases are limited to cross-platform profiles and cross-experiment profiles.
Conclusion: The pathway based gene expression similarity measuring method outperforms
commonly used similarity measuring methods. Considering the fact that public microarray database
is consist of gene expression profiles of various experiments with various type of platform, pathway
based gene expression similarity measuring method could be successfully applied for searching large
public microarray databases.
Background
As microarray experiment has been widely used for
various field of biology, public microarray databases
have been rapidly growing each year. Currently, the two
largest microarray databases, GEO [1] and ArrayExpress
[2] are comprised of several hundreds thousands of
expression profiles, representing various biological con-
texts of various species.
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scale gene expression databases, database searching
methods have been developed to make the database
easily accessible and practically useful. Since the micro-
array data is deposited in public microarray database as
unit of experiment which is consist of several individual
gene expression profiles, search methods also have
evolved into two way, experiment dataset level search
and individual gene expression profile level search.
Most of experiment dataset level search methods are
depend on dataset annotation by authors of dataset.
Atul B et al. has been tried to classify the gene expression
experiment dataset in GEO (GEO series) by annotating
each GEO dataset with medical language terms such as
U M L Sa n dS N O M E D[ 3 - 5 ]a n dt om a k eg e n ee x p r e s s i o n
variation based dataset search possible [6]. Yuelin Z et al.
built GEOmetadb [7], which make text match based
GEO dataset search more affordable than original GEO
database.
Along the attempts to search large public microarray
databases at experiment dataset level, individual gene
expression profile level search method has also been
conceptualized and developed [8]. GEST [9] is the first
implementation of individual profile level search
method. It uses Bayesian similarity metric to measure
similarity between gene expression profiles. Horton et al.
devised fast similarity search algorithm and built web
based similar gene expression search system, CellMon-
tage [10,11]. To make cross-platform gene expression
profiles search possible, they transformed all gene
expression profiles to Unigene ID based gene expression
profiles, averaging expression values of genes for
corresponding UniGene ID if multiple genes are mapped
to a single UniGene ID, then measured similarity
between expression profiles using Spearman rank corre-
lation coefficient. Cell type classification as a validation
of search power of CellMontage revealed that this
method is good enough to search similar expression
profiles from the same platform, but not from the
different platform [11].
Here we try to improve similar gene expression profile
search. For this purpose, we devised a pathway based
gene expression similarity measuring method. Our
pathway based methods outperform conventional
method especially for cross-platform and cross-experi-
ment profile search.
Methods
Gene expression data
We used set of gene expression profiles curated by
CellMontage group [11]. Each gene expression profile in
CellMontage dataset, originally stored in GEO, is
manually annotated with cell type and gene expression
values of original profiles are averaged to represent
expression values of corresponding Unigene ID.
For the classification procedure, we first selected cell
types with which at least two different platform types are
associated. For each selected cell type, we select at most
two gene expression profiles from each platform in the
same experiment. After the selection procedure, total 442
gene expression profiles of 40 different cell types from
54 different experiment with 23 different platform types
were remained (See Additional file 1). Of these selected
gene expression profiles, randomly selected one gene
expression profile from each cell type was used as query
profile and the other remaining profiles build up search
database. Finally, the numbers of gene expression
profiles in the query set and the search database are 40
and 402, respectively.
Pathway data
We used C2 database of MsigDB [12] as pathway data
source for pathway summary profiling. Each UniGene ID
in gene expression profiles was mapped to correspond-
ing gene symbol of 1,892 pathways in MsigDB using
NCBI unigene database [13].
Pathway expression profiling
Each gene expression profile was converted to pathway
centric expression profile by averaging expression values
of genes for corresponding pathways. Pathway expres-
sion for pathway k, consisted of N genes, is calculated by
P
N
G ki
i
N
=
= ∑
1
1
,
whereGi denotesgeneexpressionfor genei fori =1, ..., N.
Gene expression similarity measurement
We used two different scoring methods to measure
similarity between gene expression profiles. The first
method, conventional method used by Cellmontage,
compares common gene set between two comparing
gene expression profiles. Let this method call CGSEP
(common gene set expression profile) method. Another
method compares common pathway set between two
comparing pathway expression profiles converted from
gene expression profiles. To measure the similarity
between gene or pathway expression profiles, we used
Spearman rank correlation test. Spearman rank correla-
tion coefficient between profile X and Y is given by
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correlation coefficient ranges from -1 to 1, where
similarity is maximum at 1 and minimum at -1.
Cell type classification
To evaluate the performance of similarity measuring
methods, we conducted cell type classification using
nearest neighbor classifier. For each of 40 query gene
expression profiles, the similarities to all of 402 gene
expression profiles in search database were calculated.
Then the profile with highest Spearman rank correlation
coefficient was predicted to have the same cell type to
query profile. Predicted profile was considered as correct
prediction if its cell type is the same as that of query
sample. If there is no same cell type profile in search
database for a query profile, the search for the given
query profile is not counted in classification accuracy
assessment. Accuracy of classification is calculated by
number of correct predictions divided by number of
predictions.
Similar profile search from the profiles of different
platform or different experiment is harder than search
from the profiles of the same platform or the same
e x p e r i m e n t[ 1 0 ] .T oe v a l u a t et h ep e r f o r m a n c eo fp a t h -
way based similarity measuring method, we conducted
two more cell type classifications, cross-platform and
cross-experiment classification, where search space is
consist of profiles whose platforms or experiments are
different from that of query.
Results and discussion
We conducted cell type classification using two different
similarity measuring methods and access the perfor-
mances with overall, cross-platform and cross-experi-
ment search databases.
Barplot shown in Figure 1 summarizes all of the
classification results. Pathway based similarity measur-
ing method, PEPC, consistently shows higher classifica-
tion accuracies than CGSEP method for classifications
with three different search databases. As an example
cases, pathway based method, PEPC, precisely classified
cell types of query profile GSM18935 of thalamus cell
type with overall search database (Table 1) and query
profile GSM12641 of liver cell type with cross-platform
search database (Table 2) while CGSEP failed. Pathway
b a s e dm e t h o ds h o w ss i g n i f i c a n ti m p r o v e m e n tw h e n
they were applied for cross-platform search database
search as PEPC excel CGSEP with 48.6% increased
a c c u r a c y .P a t h w a yb a s e dm e t h o da l s oo u t p e r f o r m e du p
to 10% over CGSEP for cross-experiment search, how-
ever the improvement is not as significant as the cross-
platform classification.
We next calculated average similarity score of top scoring
hit for correct and incorrect classification cases (Table 3).
Average similarity score of correct cases is higher than
incorrect cases except cross-platform search using CGSEP
method, in which CGSEP shows only 10% classification
accuracy. Similarity scores for cross-platform search are
lower than the other two classifications. This trend is
cause by lower expression variations between expression
profiles of the same type of platforms than that of
different type of platforms [14-16].
We analyzed further to figure out the reason for low
classification accuracy of cross-experiment search. More
specifically, our question is why cross-experiment
searches show lower classification accuracy than that of
cross-platform searches even though the similarity scores
for top hits are higher than that of cross-platform searches.
To answer this question, we divided cross-experiment
search database more specifically into cross-experiment
with the same platform profiles and cross-experiment with
different platform profiles and conducted cell type
Figure 1
Cell type classification accuracy.C e l lt y p ec l a s s i f i c a t i o n
accuracies using CGSEP and PEPC for three different search
databases, overall, cross-platform and cross-experiment.
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Scoring method Similarity score Profile ID Cell type Platform ID Study ID
CGSEP 0.31 GSM19143 colon GPL97 GSE1152
0.3 GSM19142 ileum GPL97 GSE1152
0.28 GSM11827 kidney GPL97 GSE781
0.25 GSM11810 kidney GPL97 GSE781
0.24 GSM4230 skeletal GPL246 GSE465
0.24 GSM4231 skeletal GPL246 GSE465
0.23 GSM18443 cardiac GPL570 GSE1145
0.22 GSM18809 placenta GPL1074 GSE1133
0.22 GSM18798 prostate GPL1074 GSE1133
0.22 GSM18711 leukocyte GPL1074 GSE1133
PEPC 0.43 GSM2831 liver GPL91 GSE96
0.43 GSM12640 liver GPL92 GSE803
0.43 GSM2854 trachea GPL91 GSE96
0.42 GSM2858 spleen GPL91 GSE96
0.42 GSM18949 lung GPL96 GSE1133
0.42 GSM18950 lung GPL96 GSE11750
0.42 GSM2835 spleen GPL91 GSE96
0.42 GSM2844 liver GPL91 GSE96
0.41 GSM2834 salivary GPL91 GSE96
0.41 GSM12718 liver GPL8300 GSE803
Table 1: Top 10 scoring profiles for test profile GSM18935 (thalamus) with overall search database
Scoring method Similarity score Profile ID Cell type Platform ID Study ID
CGSEP 0.62 GSM12688 brain GPL8300 GSE803
0.61 GSM12708 brain GPL8300 GSE803
0.6 GSM12703 spinal GPL8300 GSE803
0.59 GSM12753 spinal GPL8300 GSE803
0.58 GSM2885 caudate GPL91 GSE96
0.58 GSM2820 cerebral GPL91 GSE96
0.58 GSM2886 caudate GPL91 GSE96
0.58 GSM2881 thalamus GPL91 GSE96
0.58 GSM18443 cardiac GPL570 GSE1145
0.57 GSM2897 thalamus GPL91 GSE96
PEPC 0.86 GSM2881 thalamus GPL91 GSE96
0.86 GSM2897 thalamus GPL91 GSE96
0.84 GSM2885 caudate GPL91 GSE96
0.83 GSM2886 caudate GPL91 GSE96
0.83 GSM2884 amygdala GPL91 GSE96
0.83 GSM2820 cerebral GPL91 GSE96
0.83 GSM2828 brain GPL91 GSE96
0.82 GSM2874 amygdala GPL91 GSE96
0.82 GSM12708 brain GPL8300 GSE803
0.82 GSM12688 brain GPL8300 GSE803
Table 3: Average similarity scores of top scoring results
Scoring method Type of top hit Overall Cross-platform Cross-study
CGSEP Correct 0.91 ± 0.04 0.54 ± 0.12 0.89 ± 0.05
Incorrect 0.82 ± 0.05 0.54 ± 0.17 0.78 ± 0.11
PEPC Correct 0.97 ± 0.03 0.74 ± 0.17 0.91 ± 0.06
Incorrect 0.84 ± 0 0.69 ± 0.18 0.84 ± 0.09
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summarizes the classification accuracy with average simi-
larity scores for correct and incorrect cases for limited
search databases. We found again improved classification
accuracies with up to 40% higher accuracy compared to
originalcross-experimentsearchbypathwaybasedmethod
if cross-experiment search is limited to cross-platform, but
this trend is disappeared in search over cross-experiment
and the same platform search databases. The average
similarity scores to the top hits of same platform top hits
are higher than average similarity scores to the top hits of
different platforms in cross-experiment search. Even
average similarity scores of incorrect cases with the same
platform arehigherthanaveragesimilarityscores of correct
cases with different platforms. Therefore, the correct
profiles of different platforms to the query profile might
not score higher than incorrect profiles of the same
platforms. This seemed to be the reason for low classifica-
tion accuracy of cross-experiment search. Considering this
reason for low classification accuracy of cross-experiment
search, different criteria to evaluate similarity score
according to platform type could improve classification
accuracy of cross-experiment search.
Reduced analytical dimension of pathway expression
profiles from gene expression profiles might also
contribute improved classification accuracy by pathway
based methods. Not all genes in gene expression profile
are converted to pathway expression profile for the
incompleteness of current pathway information [12,17].
In case of 442 query and profiles in search database used
for cell type classification, average 56 ± 15% genes of
common gene set for CGSEP method are made up
common pathway expression profiles in PEPC. However,
the reduced gene expression dimension dose not reduces
analytical sensitivity, rather it was reported that classifi-
cation accuracy is decreased with the addition of feature
genes over than the moderate number [18,19]. Likewise,
reduced number of genes in the process of pathway
expression profiling might increase analytical sensitivity
by limiting analytical dimension under moderate size.
We first attempted to use pathway information for gene
expression similarity measurement. As previously devel-
oped pathway based gene expression analysis methods
were successfully improve intact gene expression based
analysis methods [20-23], pathway based similarity mea-
suring method outperformed conventional method. Along
with the reduced analytical dimension effect described
earlier, this improvement seems to be contributed by the
averaging effect of expression variation of individual genes
caused by both biological and technical reasons. Each
human gene do not express or is not detected to expressed
constantly even under the same biological condition within
a specific microarray platform or across different type of
platforms, rather it fluctuates [24,25]. On the other hands,
pathway expression, an overall expression pattern of gene
set, is robust toward subtle outside stimulation [26]. The
pathway based gene expression similarity measuring
methods, PEPC, we suggested here, compute pathway
level expression by averaging expression of genes mapped
to pathway.
Consequently, expression variations of multiple genes
are summarized by a robust pathway expression, which
represents the activity of the functional unit rather than a
component of the unit, thus the pathway based methods
result with higher classification accuracy, which demon-
strates again that pathway level expression is more
robust than individual gene level expression and path-
way based similarity scoring methods could be success-
fully improve similar gene expression profile search.
Conclusion
We demonstrated that our new gene expression similar-
ity measuring method improved the precision of similar
gene expression profile search when it’s applied to cell
type classification. We showed pathway expression
profiling based similarity measuring method outper-
formed conventional gene expression profile based
similarity measuring method over at most 50% for
cross-platform profile search and 10% for cross-experi-
ment profile search. At the same time, the classification
accuracy shows that the methods still need to be
improved, especially for searching similar profiles across
different experiment. We believe that our research shed
new light on similar gene expression profile search over
rapidly growing large microarray databases by showing
that integrating gene expression profile with external
data such as pathway could improve search accuracy.
Table 4: Cross-experiment classification results with different search spaces
Scoring Method Cross-experiment (Same platform) Cross-experiment (Different platform)
Accuracy (%) Average correct
score
Average Incorrect
score
Accuracy (%) Average correct
score
Average Incorrect
score
CGSEP 17.5 0.89 ± 0.05 0.73 ± 0.24 10 0.54 ± 0.12 0.54 ± 0.17
PEPC 15 0.95 ± 0.06 0.77 ± 0.25 55 0.74 ± 0.17 0.7 ± 0.18
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